The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Bacterial efflux pump inhibitors from natural sources
Abstract
The rapid spread of bacteria expressing multidrug resistance (MDR) has necessitated the discovery of new antibacterials and resistance-modifying agents. Since the initial discovery of bacterial efflux pumps in the 1980s, many have been characterized in community- and hospital-acquired Gram-positive and Gram-negative pathogens, such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and, more recently, in mycobacteria. Efflux pumps are able to extrude structurally diverse compounds, including antibiotics used in a clinical setting; the latter are rendered therapeutically ineffective. Antibiotic resistance can develop rapidly through changes in the expression of efflux pumps, including changes to some antibiotics considered to be drugs of last resort. It is therefore imperative that new antibiotics, resistance-modifying agents and, more specifically, efflux pump inhibitors (EPIs) are characterized. The use of bacterial resistance modifiers such as EPIs could facilitate the re-introduction of therapeutically ineffective antibiotics back into clinical use such as ciprofloxacin and might even suppress the emergence of MDR strains. Here we review the literature on bacterial EPIs derived from natural sources, primarily those from plants. The resistance-modifying activities of many new chemical classes of EPIs warrant further studies to assess their potential as leads for clinical development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,540
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
Self-citationClinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
Self-citationVancomycin-Resistant Enterococci
Cetinkaya, Y., Falk, P., & Mayhall, C. G. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.686 · Cited by 1,163
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
Chambers, H. F. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.4.781 · Cited by 1,127
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
Antibiotics in laboratory medicine
Hausler, W. J. (1997) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00063-1 · Cited by 1,029
Update on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S., Renau, T., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.105-116.2001 · Cited by 903
The emergence and evolution of methicillin-resistant Staphylococcus aureus
Hiramatsu, K., Cui, L., Kuroda, M., & Ito, T. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02175-8 · Cited by 825
Stermitz, F. R., Lorenz, P., Tawara, J. N., Zenewicz, L. A., & Lewis, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030540597 · Cited by 761
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 628
McMurry, L., Petrucci, R. E., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 604
Multidrug Pump Inhibitors Uncover Remarkable Activity of Plant Antimicrobials
Tegos, G., Stermitz, F. R., Lomovskaya, O., & Lewis, K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3133-3141.2002 · Cited by 517
Mechanisms of bacterial biocide and antibiotic resistance: ANTIBIOTIC AND BIOCIDE RESISTANCE
Poole, K. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.8.x · Cited by 513
Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus
Kaatz, G. W., Seo, S. M., & Ruble, C. A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1086 · Cited by 413
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
Neyfakh, A. A., Bidnenko, V. E., & Chen, L. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4781 · Cited by 371
Antibacterial and resistance modifying activity of
OLUWATUYI, M., KAATZ, G., & GIBBONS, S. (2004) · Phytochemistry · doi:10.1016/j.phytochem.2004.10.009 · Cited by 362
Self-citationFluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter
Neyfakh, A. A., Borsch, C. M., & Kaatz, G. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.128 · Cited by 361
Role of mycobacterial efflux transporters in drug resistance: an unresolved question
Rossi, E. D., Aínsa, J. A., & Riccardi, G. (2006) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2005.00002.x · Cited by 328
Blumberg, H. M., Rimland, D., Carroll, D. J., Terry, & Wachsmuth, I. K. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1279 · Cited by 319
Vancomycin-resistant Staphylococcus aureus
Howe, R. A., Bowker, K. E., Walsh, T. R., Feest, T. G., & MacGowan, A. P. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78597-4 · Cited by 274
Baranova, N., & Nikaido, H. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.15.4168-4176.2002 · Cited by 273
Inducible NorA-mediated multidrug resistance in Staphylococcus aureus
Kaatz, G. W., & Seo, S. M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2650 · Cited by 268
Sudano Roccaro, A., Blanco, A. R., Giuliano, F., Rusciano, D., & Enea, V. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.1968-1973.2004 · Cited by 263
Gill, M. J., Brenwald, N. P., & Wise, R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.187 · Cited by 259
Potent Synergism of the Combination of Fluconazole and Cyclosporine in Candida albicans
Marchetti, O., Moreillon, P., Glauser, M. P., Bille, J., & Sanglard, D. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2373-2381.2000 · Cited by 252
Piperine, a Phytochemical Potentiator of Ciprofloxacin against Staphylococcus aureus
Khan, I. A., Mirza, Z. M., Kumar, A., Verma, V., & Qazi, G. N. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.810-812.2006 · Cited by 248
Aminoglycoside-modifying enzymes
Wright, G. D. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00007-7 · Cited by 241
Phenothiazines and Thioxanthenes Inhibit Multidrug Efflux Pump Activity in Staphylococcus aureus
Kaatz, G. W., Moudgal, V. V., Seo, S. M., & Kristiansen, J. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.719-726.2003 · Cited by 224
Plants as a Source of Bacterial Resistance Modulators and Anti-Infective Agents
Gibbons, S. (2005) · Phytochemistry Reviews · doi:10.1007/s11101-005-2494-9 · Cited by 220
Self-citationLomovskaya, O., Lee, A., Hoshino, K., Ishida, H., Mistry, A., Warren, M. S., Boyer, E., Chamberland, S., & Lee, V. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1340 · Cited by 220
Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus
Braga, L. C., Leite, A. A. M., Xavier, K. G. S., Takahashi, J. A., Bemquerer, M. P., Chartone-Souza, E., & Nascimento, A. M. A. (2005) · Canadian Journal of Microbiology · doi:10.1139/w05-022 · Cited by 214
A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus
Gibbons, S. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg044 · Cited by 213
Self-citationGibbons, S., & Udo, E. E. (2000) · Phytotherapy Research · doi:10.1002/(sici)1099-1573(200003)14:2<139::aid-ptr608>3.0.co;2-8 · Cited by 207
Self-citationO-Acetyltransferases for chloramphenicol and other natural products
Murray, I. A., & Shaw, W. V. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.1 · Cited by 205
Antimalarial activity of Artemisia annua flavonoids from whole plants and cell cultures
Liu, K. C.-S., Yang, S.-L., Roberts, M. F., Elford, B. C., & Phillipson, J. D. (1992) · Plant Cell Reports · doi:10.1007/bf00236389 · Cited by 189
Arcangioli, M. (1999) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(99)00161-5 · Cited by 182
Rotun, S. S., McMath, V., Schoonmaker, D. J., Maupin, P. S., Tenover, F. C., Hill, B. C., & Ackman, D. M. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0501.990118 · Cited by 167
Fujita, M., Shiota, S., Kuroda, T., Hatano, T., Yoshida, T., Mizushima, T., & Tsuchiya, T. (2005) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2005.tb03732.x · Cited by 164
Schmitz, F. J., Fluit, A. C., Luckefahr, M., Engler, B., Hofmann, B., Verhoef, J., Heinz, H. P., Hadding, U., & Jones, M. E. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.6.807 · Cited by 161
Guz, N. R., Stermitz, F. R., Johnson, J. B., Beeson, T. D., Willen, S., Hsiang, J.-F., & Lewis, K. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0004190 · Cited by 155
Yam, T., Hamilton-Miller, J. M., & Shah, S. S. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.211 · Cited by 153
Isoflavones As Potentiators of Antibacterial Activity
Morel, C., Stermitz, F. R., Tegos, G. P., & Lewis, K. (2003) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0302714 · Cited by 149
Aminoglycoside antibiotics. Structures, functions, and resistance.
Wright, G. D., Berghuis, A. M., & Mobashery, S. (1998) · PubMed · Cited by 146
Li, X.-Z., Poole, K., & Nikaido, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.27-33.2003 · Cited by 144
Belofsky, G., Percivill, D., Lewis, K., Tegos, G. P., & Ekart, J. (2004) · Journal of Natural Products · doi:10.1021/np030409c · Cited by 143
Aminoglycoside Antibiotics: Structures, Functions, and Resistance
Wright, G. D., Berghuis, A. M., & Mobashery, S. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4897-3_4 · Cited by 138
Samosorn, S., Bremner, J. B., Ball, A. R., & Lewis, K. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.09.019 · Cited by 137
Kaatz, G. W., Seo, S. M., O'Brien, L., Wahiduzzaman, M., & Foster, T. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.5.1404-1406.2000 · Cited by 134
The threat of vancomycin resistance
Perl, T. M. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00354-4 · Cited by 134
Bacterial resistance modifying agents from Lycopus europaeus
Gibbons, S., Oluwatuyi, M., Veitch, N. C., & Gray, A. I. (2002) · Phytochemistry · doi:10.1016/s0031-9422(02)00446-6 · Cited by 126
Self-citationSmith, E. C. J., Williamson, E. M., Zloh, M., & Gibbons, S. (2005) · Phytotherapy Research · doi:10.1002/ptr.1711 · Cited by 124
Self-citationBerberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin
Musumeci, R., Speciale, A. M., Costanzo, R., Annino, A., Ragusa, S., Rapisarda, A., Pappalardo, M. S., & Iauk, L. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00085-2 · Cited by 118
Stermitz, F. R., Scriven, L. N., Tegos, G., & Lewis, K. (2002) · Planta Medica · doi:10.1055/s-2002-36347 · Cited by 114
Catechin Gallates Inhibit Multidrug Resistance (MDR) inStaphylococcus aureus
Gibbons, S., Moser, E., & Kaatz, G. W. (2004) · Planta Medica · doi:10.1055/s-2004-835860 · Cited by 112
Self-citationMarkham, P. N., & Neyfakh, A. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2673 · Cited by 111
Ball, P. R., Shales, S. W., & Chopra, I. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(80)80247-6 · Cited by 108
Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance
Lee, M. D., Galazzo, J. L., Staley, A. L., Lee, J. C., Warren, M. S., Fuernkranz, H. A., Chamberland, S., Lomovskaya, O., & Miller, G. H. (2001) · Il Farmaco · doi:10.1016/s0014-827x(01)01002-3 · Cited by 102
Pereda‐Miranda, R., Kaatz, G. W., & Gibbons, S. (2005) · Journal of Natural Products · doi:10.1021/np050227d · Cited by 100
Self-citationMarkham, P. N. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.988 · Cited by 97
Multidrug resistance reversal agent from Jatropha elliptica
Marquez, B., Neuville, L., Moreau, N. J., Genêt, J., dos Santos, A. F., ANDRADE, M. C. C. D., & Santana, A. E. G. (2005) · Phytochemistry · doi:10.1016/j.phytochem.2005.06.008 · Cited by 97
Kaatz, G. W. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00220-6 · Cited by 93
Coronado, V. G., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, T. N. N. I. S. (. (1995) · Infection Control and Hospital Epidemiology · doi:10.2307/30140945 · Cited by 86
Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr
Klyachko, K. A., Schuldiner, S., & Neyfakh, A. A. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.7.2189-2193.1997 · Cited by 83
Brenwald, N. P., Gill, M. J., & Wise, R. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.458 · Cited by 75
Robertson, G. T., Doyle, T. B., & Lynch, A. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4781-4783.2005 · Cited by 74
Stermitz, F. R., Beeson, T. D., Mueller, P. J., Hsiang, J.-F., & Lewis, K. (2001) · Biochemical Systematics and Ecology · doi:10.1016/s0305-1978(01)00025-4 · Cited by 72
Stermitz, F. R., Cashman, K. K., Halligan, K. M., Morel, C., Tegos, G. P., & Lewis, K. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00316-0 · Cited by 70
Harnett, N., Brown, S. N., & Krishnan, C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1911 · Cited by 69
Kristiansen, M. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00200-0 · Cited by 68
Abulrob, A., Suller, M. T. E., Gumbleton, M., Simons, C., & Russell, A. D. (2004) · Phytochemistry · doi:10.1016/j.phytochem.2004.08.044 · Cited by 68
Antibacterial Activity of Juliflorine Isolated fromProsopis juliflora
Ahmad, A., Khan, K. A., Ahmad, V. U., & Qazi, S. (1986) · Planta Medica · doi:10.1055/s-2007-969153 · Cited by 66
Hamilton-Miller, J. M. T. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.5.852 · Cited by 64
Kaatz, G. W., Moudgal, V. V., & Seo, S. M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf224 · Cited by 62
Accumulation of 10 Fluoroquinolones by Wild-Type or Efflux Mutant Streptococcus pneumoniae
Piddock, L. J. V., & Johnson, M. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.813-820.2002 · Cited by 55
Self-citationPrice, C. T. D., Kaatz, G. W., & Gustafson, J. E. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00162-0 · Cited by 54
Marrer, E., Satoh, A. T., Johnson, M. M., Piddock, L. J. V., & Page, M. G. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.269-278.2006 · Cited by 49
Self-citationInhibitors of multidrug resistance (MDR) have affinity for MDR substrates
Zloh, M., Kaatz, G. W., & Gibbons, S. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.015 · Cited by 47
Self-citationBabayan, A., & Nikaido, H. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.146 · Cited by 17
Cited by
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Vaou, N., Stavropoulou, E., Voidarou, C., Tsigalou, C., & Bezirtzoglou, E. (2021) · Microorganisms · doi:10.3390/microorganisms9102041 · Cited by 993
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Drug combinations: a strategy to extend the life of antibiotics in the 21st century
Tyers, M., & Wright, G. D. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0141-x · Cited by 820
Metadata
- Authors
- Stavri, M., Piddock, L. J. V., & Gibbons, S.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-12-04
- Volume
- 59
- Issue
- 6
- Pages
- 1247-1260
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2159355055
- Cited by
- 547
- References
- 85
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.